We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




AI Method Accurately Predicts Breast Cancer Risk by Analyzing Multiple Mammograms

By HospiMedica International staff writers
Posted on 09 Dec 2024

Currently, there is no way to predict who is at risk of developing breast cancer based on mammogram images alone. More...

While some risk-reduction strategies are available, such as the use of tamoxifen, these treatments may cause unwanted side effects. Most high-risk women are offered more frequent screenings or the option to include additional imaging methods, like MRIs, to detect cancer early. Now, a new study published in JCO Clinical Cancer Informatics introduces a breakthrough approach to analyzing mammograms, significantly enhancing the accuracy of predicting a woman’s risk of developing breast cancer in the next five years. By incorporating up to three years of previous mammograms, this new method identified individuals at high risk of developing breast cancer 2.3 times more accurately than the standard method, which relies solely on questionnaires about clinical risk factors such as age, race, and family history.

This risk-prediction model builds upon previous research conducted by Washington University School of Medicine (St. Louis, MO, USA), which revealed that earlier mammograms contain valuable insights into the early stages of breast cancer that may go unnoticed by even well-trained professionals. These insights include subtle shifts in breast density, which measures the relative amounts of fibrous and fatty tissue in the breasts. In the latest study, the team developed an artificial intelligence-based algorithm that can detect minute differences in mammograms, helping to identify women at the highest risk of developing breast cancer over a specific time period. Apart from breast density, the algorithm also evaluates other patterns, such as changes in texture, calcification, and asymmetry in the images. The new method is capable of spotting small changes over time in repeated mammogram images that are not visible to the human eye but are rich in information crucial for identifying high-risk individuals.

The researchers trained their machine-learning algorithm using mammograms from more than 10,000 women who had breast cancer screenings between 2008 and 2012. These women were followed until 2020, with 478 diagnosed with breast cancer during that period. The team then applied their method to a separate dataset of over 18,000 women who had mammograms between 2013 and 2020, with 332 of these women being diagnosed with breast cancer during follow-up. According to the new prediction model, women identified as high-risk were 21 times more likely to be diagnosed with breast cancer in the next five years compared to those in the lowest-risk group. In the high-risk group, 53 out of every 1,000 women screened developed breast cancer, while in the low-risk group, only 2.6 women per 1,000 screened developed breast cancer. In comparison, the older, questionnaire-based method correctly identified only 23 women per 1,000 as high-risk, missing 30 breast cancer cases that the new method detected.

The mammograms were taken from both academic medical centers and community clinics, demonstrating that the accuracy of this method remains consistent across various healthcare settings. Importantly, the algorithm was designed with significant representation of Black women, a group often underrepresented in breast cancer risk models. The predictive accuracy was consistent across racial groups. Ongoing work includes testing the algorithm in women from diverse racial and ethnic backgrounds, including Asian, Southeast Asian, and Native American women, to ensure its effectiveness for all populations. The researchers are also working on securing patents and licensing for this new method, with plans to make it widely available wherever screening mammograms are provided.

“Today, we don’t have a way to know who is likely to develop breast cancer in the future based on their mammogram images,” said co-author Debbie L. Bennett, MD, an associate professor of radiology and chief of breast imaging for the Mallinckrodt Institute of Radiology at WashU Medicine. “What’s so exciting about this research is that it indicates that it is possible to glean this information from current and prior mammograms using this algorithm. The prediction is never going to be perfect, but this study suggests the new algorithm is much better than our current methods.”


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Medical Examination & Procedure Light
Vega 80
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.